FIELD: medicine.
SUBSTANCE: presented promoter consists of a sequence of the length of 3574 base pairs above an initial point of the human transcription gene NDUFV1 with a remote sequence of the length of 91 base pairs immediately above the initial point of said gene transcription.
EFFECT: invention provides creating an artificial strong promoter which may be applicable for the therapy of terminal tissues, producing transgenic animals or modified cell lines with the desired functions.
5 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR GENE THERAPY OF MALIGNANT GROWTHS | 2010 |
|
RU2447150C1 |
| MULTIPURPOSE CANCER-SPECIFIC PROMOTERS AND USING THEM IN ANTI-CANCER THERAPY | 2013 |
|
RU2539764C2 |
| REPORTER SYSTEM BASED ON LENTIVIRUS REPORTER STRUCTURES FOR STUDY OF PROTEIN-PROTEIN INTERACTIONS | 2015 |
|
RU2639539C2 |
| MULTI-PURPOSE PROMOTER, EXPRESSION VECTOR, AND METHOD OF SELECTIVE KILLING CANCER CELLS WITH THEIR USE | 2012 |
|
RU2476596C1 |
| PIGAS CELL LINE CONTAINING STAT-1 TRANSCRIPTION FACTOR BINDING SITE STABLE-INTEGRATED IN GENOME | 2015 |
|
RU2619643C1 |
| UNIVERSAL PROMOTER FOR EXPRESSION OF THERAPEUTIC GENES IN MAMMALIAN CELLS | 2013 |
|
RU2551784C1 |
| METHOD FOR DETECTION OF TUMOUR GROWTH Pdcd4 SUPPRESSOR SUPPRESSION INHIBITORS IN TUMOUR CELLS AND pLucPdcd4 GENETIC CONSTRUCT FOR ITS IMPLEMENTATION | 2016 |
|
RU2640909C1 |
| METHOD FOR DETECTING REGULATORY ELEMENTS OF GENOME AND GENETIC CONSTRUCT FOR USE IN SAID METHOD | 2023 |
|
RU2822825C1 |
| EXPRESSION VECTOR FOR TRANSGENIC INTRODUCTION INTO CELLS AND TISSUES OF MAMMALS WITH REGULATED NON-VIRAL PROMOTOR | 2011 |
|
RU2495128C2 |
| METHODS AND COMPONENTS FOR INDUCTION OF TUMOR- -SPECIFIC CYTOTOXICITY | 1998 |
|
RU2214280C2 |
